Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Institute Board of Scientific Advisors.
The meeting will be held virtually and is open to the public. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting will be videocast and can be accessed from the NIH Videocasting and Podcasting Website ( http://videocast.nih.gov/ ).
Name of Committee: National Cancer Institute Board of Scientific Advisors.
Date: March 15, 2021.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: Director's Report; RFA, RFP, and PAR Concept Reviews; and Scientific Presentations.
Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting).
Date: March 16, 2021.
Time: 1:00 p.m. to 5:30 p.m.
Agenda: RFA, RFP, and PAR Concept Reviews; and Scientific Presentations.
Place: National Cancer Institute—Shady Grove, 9609 Medical Center Drive, Rockville, MD 20850 (Virtual Meeting).
Contact Person: Paulette S. Gray, Ph.D., Director, Division of Extramural Activities, National Cancer Institute—Shady Grove, National Institutes of Health, 9609 Medical Center Drive, Room 7W444, Bethesda, MD 20892, 240-276-6340, grayp@mail.nih.gov.
Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person.
Information is also available on the Institute's/Center's home page: BSA: http://deainfo.nci.nih.gov/advisory/bsa/bsa.htm,, where an agenda and any additional information for the meeting will be posted when available.
This notice is being published less than 15 days prior to the meeting due to scheduling difficulties.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS)
Dated: March 1, 2021.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-04518 Filed 3-4-21; 8:45 am]
BILLING CODE 4140-01-P